2hff: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2hff.gif|left|200px]] | [[Image:2hff.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2hff", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
| | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| | or leave the SCENE parameter empty for the default display. | ||
--> | |||
{{STRUCTURE_2hff| PDB=2hff | SCENE= }} | |||
}} | |||
'''Crystal structure of CB2 Fab''' | '''Crystal structure of CB2 Fab''' | ||
Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HFF OCA]. | |||
==Reference== | ==Reference== | ||
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells., Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai SP, Compaan DM, Yin J, Gong Q, Kelley RF, DeForge LE, Martin F, Starovasnik MA, Fuh G, Blood. 2006 Nov 1;108(9):3103-11. Epub 2006 Jul 13. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16840730 16840730] | Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells., Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai SP, Compaan DM, Yin J, Gong Q, Kelley RF, DeForge LE, Martin F, Starovasnik MA, Fuh G, Blood. 2006 Nov 1;108(9):3103-11. Epub 2006 Jul 13. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16840730 16840730] | ||
[[Category: Hymowitz, S G.]] | [[Category: Hymowitz, S G.]] | ||
[[Category: | [[Category: Combinatorial selection]] | ||
[[Category: | [[Category: Fab fragment]] | ||
[[Category: | [[Category: Phage library]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 06:13:41 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |